Yan Fan

1.9k total citations
67 papers, 1.5k citations indexed

About

Yan Fan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yan Fan has authored 67 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 23 papers in Pulmonary and Respiratory Medicine and 23 papers in Oncology. Recurrent topics in Yan Fan's work include Advanced Breast Cancer Therapies (10 papers), Cancer-related Molecular Pathways (7 papers) and Immunotherapy and Immune Responses (7 papers). Yan Fan is often cited by papers focused on Advanced Breast Cancer Therapies (10 papers), Cancer-related Molecular Pathways (7 papers) and Immunotherapy and Immune Responses (7 papers). Yan Fan collaborates with scholars based in China, United States and Singapore. Yan Fan's co-authors include Hui Li, Xiubao Ren, Rong Xiang, Cihui Yan, Jinpu Yu, Hua Zhao, Yanhua Liu, Tianqi Wang, William H. Flurkey and Zhi Huang and has published in prestigious journals such as The Journal of Immunology, Biomaterials and Scientific Reports.

In The Last Decade

Yan Fan

65 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Fan China 20 695 453 353 304 209 67 1.5k
Shengzhang Lin China 15 489 0.7× 499 1.1× 354 1.0× 254 0.8× 138 0.7× 35 1.4k
Ryszard Smolarczyk Poland 18 647 0.9× 373 0.8× 340 1.0× 214 0.7× 137 0.7× 48 1.4k
Tomasz Cichoń Poland 19 698 1.0× 378 0.8× 348 1.0× 221 0.7× 142 0.7× 58 1.4k
Yihui Shi United States 21 841 1.2× 493 1.1× 276 0.8× 386 1.3× 138 0.7× 50 1.8k
Hongsheng Wang China 21 845 1.2× 575 1.3× 195 0.6× 337 1.1× 204 1.0× 49 1.6k
Tao Fang China 25 1.0k 1.5× 457 1.0× 308 0.9× 446 1.5× 108 0.5× 53 1.8k
Jacinta Serpa Portugal 26 1.1k 1.5× 319 0.7× 263 0.7× 501 1.6× 257 1.2× 77 2.0k
Sang‐Yeob Kim South Korea 24 797 1.1× 440 1.0× 271 0.8× 262 0.9× 240 1.1× 81 1.6k
Khalil Hajiasgharzadeh Iran 23 751 1.1× 488 1.1× 348 1.0× 410 1.3× 172 0.8× 69 1.5k

Countries citing papers authored by Yan Fan

Since Specialization
Citations

This map shows the geographic impact of Yan Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Fan more than expected).

Fields of papers citing papers by Yan Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Fan. The network helps show where Yan Fan may publish in the future.

Co-authorship network of co-authors of Yan Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Fan. A scholar is included among the top collaborators of Yan Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Fan. Yan Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaoxue, Cheng Wang, Yakun Ma, et al.. (2025). Discovery of a Novel EGFR PROTAC Degrader against C797S Resistance Mutation with Potent Antitumor Efficacy in NSCLC Treatment. Journal of Medicinal Chemistry. 68(14). 14569–14593.
2.
Wang, Xiaoxue, Kejia Xu, Beilei Zeng, et al.. (2024). Novel EGFR inhibitors against resistant L858R/T790M/C797S mutant for intervention of non-small cell lung cancer. European Journal of Medicinal Chemistry. 277. 116711–116711. 17 indexed citations
3.
Tong, Wei, Shingo Nakayamada, Shan Yu, et al.. (2024). Amelioration of immunoglobulin A vasculitis by suppression of the pathological expansion of T follicular helper 17 cells. Journal of Autoimmunity. 149. 103304–103304. 3 indexed citations
4.
Liu, Zhen, et al.. (2024). Investigation of tumour environments through advancements in microtechnology and nanotechnology. Biomedicine & Pharmacotherapy. 178. 117230–117230. 1 indexed citations
6.
Liu, Naixin, Yan Fan, Yilin Li, et al.. (2023). OL-FS13 Alleviates Cerebral Ischemia-reperfusion Injury by InhibitingmiR-21-3p Expression. Current Neuropharmacology. 21(12). 2550–2562. 2 indexed citations
7.
Wang, Cheng, Xin Wang, Zhi Huang, et al.. (2022). Discovery and structural optimization of potent epidermal growth factor receptor (EGFR) inhibitors against L858R/T790M/C797S resistance mutation for lung cancer treatment. European Journal of Medicinal Chemistry. 237. 114381–114381. 12 indexed citations
8.
Fan, Yan, Zhi Huang, Xiaoshuang Wang, et al.. (2020). Discovery of 12O—A Novel Oral Multi-Kinase Inhibitor for the Treatment of Solid Tumor. Molecules. 25(21). 5199–5199. 4 indexed citations
9.
Fan, Yan, Bo Pan, Huichao Sun, Jie Tian, & Mi Li. (2019). Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis. Frontiers in Pediatrics. 7. 374–374. 38 indexed citations
10.
Wang, Cheng, Xin Wang, Yao Li, et al.. (2019). Design and optimization of orally spleen tyrosine kinase (SYK) inhibitors for treatment of solid tumor. Bioorganic Chemistry. 95. 103547–103547. 12 indexed citations
11.
Wang, Chengyu, Yan Fan, Xiaofeng He, & Aoying Zhou. (2018). Decoding Chinese User Generated Categories for Fine-Grained Knowledge Harvesting. IEEE Transactions on Knowledge and Data Engineering. 31(8). 1491–1505. 2 indexed citations
12.
Shen, Wenzhi, Xiaoyuan Zhang, Renle Du, et al.. (2018). ICAM3 mediates tumor metastasis via a LFA-1-ICAM3-ERM dependent manner. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(8). 2566–2578. 16 indexed citations
13.
Zhou, Wei, Yongtao Li, Mei Cao, et al.. (2018). Novel hybrid molecule overcomes the limited response of solid tumours to HDAC inhibitors via suppressing JAK1-STAT3-BCL2 signalling. Theranostics. 8(18). 4995–5011. 49 indexed citations
14.
Zhou, Lei, Heng Zhang, Manling Huang, et al.. (2017). Clinical, endoscopic and pathological characteristics of colorectal polyps in elderly patients: Single-center experience. Molecular and Clinical Oncology. 7(1). 81–87. 6 indexed citations
15.
Fan, Yan, Han Wei Hou, Hui Min Tay, et al.. (2017). Preservation of Anticancer and Immunosuppressive Properties of Rapamycin Achieved Through Controlled Releasing Particles. AAPS PharmSciTech. 18(7). 2648–2657. 14 indexed citations
16.
Li, Hui, et al.. (2015). Osteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resection. Journal of Cancer Research and Clinical Oncology. 141(8). 1371–1378. 15 indexed citations
17.
Ding, Tingting, et al.. (2015). Regulatory B cell: New member of immunosuppressive cell club. Human Immunology. 76(9). 615–621. 36 indexed citations
18.
Wang, Yang, Xujie Gao, Feng Wei, et al.. (2014). The hOGG1 Ser326Cys polymorphism contributes to digestive system cancer susceptibility: evidence from 48 case–control studies. Tumor Biology. 36(2). 1029–1038. 12 indexed citations
19.
Wang, Lina, Weijun Su, Ze Liu, et al.. (2012). CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma. Biomaterials. 33(20). 5107–5114. 164 indexed citations
20.
Fan, Yan & William H. Flurkey. (2004). Purification and characterization of tyrosinase from gill tissue of Portabella mushrooms. Phytochemistry. 65(6). 671–678. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026